Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2013, Article ID 901589, 5 pages
http://dx.doi.org/10.1155/2013/901589
Clinical Study

Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans

1Department of Clinical Hematology, Yopougon Teaching Hospital, P.O. Box 632, Abidjan 21, Cote d'Ivoire
2Department of Biological Hematology, Yopougon Teaching Hospital, P.O. Box 632, Abidjan 21, Cote d'Ivoire

Received 31 March 2013; Revised 13 May 2013; Accepted 14 May 2013

Academic Editor: Giuseppe G. Saglio

Copyright © 2013 Tolo Diebkilé Aïssata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tolo Diebkilé Aïssata, Duni Sawadogo, Clotaire Nanho, et al., “Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans,” Advances in Hematology, vol. 2013, Article ID 901589, 5 pages, 2013. https://doi.org/10.1155/2013/901589.